ARID2 and lung carcinoma: No substantial difference in the positive staining of cleaved-caspase-3 (CC-3) was observed between the ARID2-knockdown and control groups (Fig. 3D and E), indicating that ARID2 mainly suppresses proliferation of lung cancer cells.